[pubmed] Myasthenia Gravis in Poland: National Healthcare Database Epidemiological Study
Posté : 21 févr. 2021 12:00
Neuroepidemiology. 2021 Feb 19:1-8. doi: 10.1159/000512973. Online ahead of print.
ABSTRACT
INTRODUCTION: Myasthenia gravis (MG) is a rare autoimmune disorder of the neuromuscular junction. MG epidemiology has not been studied in Poland in a nationwide study before.
METHODS: Our epidemiological data were drawn from the National Health Fund (Narodowy Fundusz Zdrowia, NFZ) database; an MG patient was defined as a person who received at least once medical service coded in ICD-10 as MG (G70) and at least 2 reimbursed prescriptions for pyridostigmine bromide (Mestinon®) or ambenonium chloride (Mytelase®) in 2 consecutive years.
RESULTS: On 1st of January 2019, 8,702 patients with MG were receiving symptomatic treatment (female:male ratio: 1.65:1). MG incidence was 2.36/100,000. The mean age of incident cases in 2018 was 61.37 years, 59.17 years for women and 64.12 years for men. Incidence of early-onset MG (
Source: https://pubmed.ncbi.nlm.nih.gov/3361131 ... 8&v=2.14.2